Literature DB >> 6653013

Pitfall to modified in vivo method of technetium-99m red blood cell labeling. Iodinated contrast media.

J L Tatum, T S Burke, J I Hirsch, W W Miller, M J Fratkin.   

Abstract

Suboptimal labeling of red blood cells with Tc-99m, using the modified in vivo technique, was observed in three patients in whom labeling was attempted following IV administration of iodinated contrast media in the previous 24 hours. The mechanism is not understood, but it may represent a change in either stannous ion distribution or redox potential. It is recommended that studies employing Tc-99m RBC labeling using this technique be performed prior to administration of iodinated contrast media. This effect should be kept in mind in gastrointestinal bleeding studies performed using Tc-99m RBC, as well as in cardiac imaging studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653013     DOI: 10.1097/00003072-198312000-00001

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

Review 1.  Contrast media: interactions with other drugs and clinical tests.

Authors:  Sameh K Morcos; Henrik S Thomsen; C M Exley
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

2.  Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations.

Authors:  A S Hambye; R Vandermeiren; A Vervaet; J Vandevivere
Journal:  Eur J Nucl Med       Date:  1995-01

Review 3.  Poor-quality red blood cell labelling with technetium-99m: case report and review of the literature.

Authors:  I Adalet; S Cantez
Journal:  Eur J Nucl Med       Date:  1994-02

Review 4.  Adverse reactions and drug interactions with radiopharmaceuticals.

Authors:  C B Sampson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.